Matrix Metalloproteinases as a Therapeutic Target to Improve Neurologic Recovery After Spinal Cord Injury

Abstract

Purpose: We are evaluating efficacy of GM6001, a matrix metalloproteinase (MMP) inhibitor in a murine model of spinal cord injury (UCSF) and in dogs (Texas A & M, TAMU) that sustain naturally occurring spinal cord injuries resulting from spontaneous intervertebral disk herniation (IVDH).

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Dec 01, 2015
Accession Number
ADA637014

Entities

People

  • Aida F. Martinez
  • Alpa Mahuvakar
  • Jon Levine
  • Linda J. Noble
  • Thomas Fandel

Organizations

  • University of California, San Francisco

Tags

DTIC Thesaurus Topics

  • Blood
  • Body Weight
  • Catheters
  • Chemistry
  • Clinical Trials
  • Contrast
  • Data Analysis
  • Department Of Defense
  • Information Science
  • Inhibition
  • Inhibitors
  • Recovery
  • Residuals
  • Spinal Cord
  • Spinal Injuries
  • Urinary Tract
  • Wounds And Injuries

Fields of Study

  • Medicine
  • Physics

Readers

  • Molecular Biology and Genetics
  • Neurotrauma and Rehabilitation Medicine.